• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number MDT-TRANS DCS
Device Problem Insufficient Information (3190)
Patient Problems Fistula (1862); Hematoma (1884); Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226); Stenosis (2263); Cardiac Perforation (2513); Vascular Dissection (3160); Pericardial Effusion (3271)
Event Date 11/01/2021
Event Type  Injury  
Event Description
Medtronic received information from a literature article regarding the use of intravascular lithotripsy to facilitate transfemoral t ranscatheter aortic valve implantation (tavi).All data was collected from multi-center registry between 2018 and 2020.Of the 108 patients included in the study population (predominantly male, mean age 80.5 years), approximately 42 underwent transfemoral tavi with a medtronic evolut r or evolut pro valve system.No unique device identifier numbers were provided.Among all 108 patients in the study population, 3 in-hospital deaths occurred due to failed surgical conversion after annular rupture (n = 1), sepsis (n = 1), and malignant arrhythmia caused by hyperkalemia (n = 1).No statement was made suggesting a causal or contributory relationship between medtronic product and the deaths.Although a direct correlation was not made, the following non-death adverse events mayhave been associated with medtronic transcatheter valves: emergent conversion to open-surgery due to valve embolization into the left ventricular cavity, new permanent pacemaker implantation, and mild to severe aortic regurgitation.Although a direct correlation was not made, the following non-death access-site adverse events may have been associated with medtronic delivery catheter systems: dissection, stenosis, arteriovenous fistula, retroperitoneal hematoma, major bleeding, cardiac structure perforation/injury, pericardial effusion causing cardiac tamponade requiring pericardiocentesis, and need for unplanned endovascular intervention (balloon dilation, covered or bare metal stent implant).No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
Citation: nardi g, et al.Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study.Eurointervention.2022 apr 1;17(17):e1397-e1406.Doi: 10.4244/eij-d-21-00581.Published online ahead of print november 2021.Earliest date of publish used for date of event: november 1, 2021 (month and year valid).Medtronic products: enveo r delivery catheter system (pma# p130021, product code npt), enveo pro delivery catheter system (pma# p130021, product code npt).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC TRANSCATHETER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14552395
MDR Text Key293351024
Report Number2025587-2022-01520
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMDT-TRANS DCS
Device Catalogue NumberMDT-TRANS DCS
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age81 YR
Patient SexMale
-
-